Related Experiment Video
Updated: Jun 1, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
[Independent predictors of deep vein thrombosis (results of prospective 18 months study)]
Insights
Recurrent deep vein thrombosis (DVT) is predicted by elevated D-dimer levels, a specific gene variant, and inconsistent anticoagulant therapy levels. These factors help identify patients at higher risk for DVT recurrence.
Area of Science:
- Cardiology
- Hematology
- Genetics
Background:
- Deep vein thrombosis (DVT) and pulmonary embolism (PE) are significant causes of morbidity and mortality.
- Anticoagulant therapy is the cornerstone of treatment, but recurrence remains a concern.
- Identifying predictors of recurrence is crucial for optimizing patient management.
Purpose of the Study:
- To identify independent predictors of recurrent DVT and PE in patients treated with anticoagulants.
- To evaluate the association of various demographic, clinical, genetic, and laboratory parameters with recurrence risk.
Main Methods:
- Prospective follow-up of 90 patients with DVT and/or PE for 18 months.
- Analysis of 165 parameters including demographic, anthropometric, clinical, genetic, instrumental, and laboratory data.
- Multifactorial regression analysis to determine independent predictors of recurrence.
Main Results:
- The recurrence rate of DVT was 16.7% during the 18-month follow-up; no PE recurrences were observed.
- Elevated D-dimer levels after one month of anticoagulant therapy were a significant predictor (RR 8.1).
- Homozygosity for the C249T polymorphism in the beta-fibrinogen gene (RR 8.4) and a lower percentage of time within the therapeutic INR range (RR 0.94) were also independent predictors of DVT recurrence.
Conclusions:
- Elevated D-dimer, specific genetic predisposition (beta-fibrinogen C249T homozygosity), and suboptimal anticoagulation control are key predictors of recurrent DVT.
- These findings can aid in risk stratification and personalized treatment strategies for patients with DVT.
Abstract:
We followed for 18 months 90 patients who had had deep vein thrombosis (DVE) and/or pulmonary embolism (PE) and received therapy with anticoagulants either for 3-12 months or for indefinitely long time. During follow-up rate of recurrent DVE was 16.7%, no recurrences of PE were registered. Predictors of recurrent PE were selected among 165 demographic, anthropometric, anamnestic, clinical, genetic, instrumental, and laboratory parameters, as well as risk factors of development of thromboembolic complications. According to results of multifactorial regression analysis we established the following independent predictors recurrent DVE during 18 months of follow-up: elevated level of DAdimer after 1 month of anticoagulant therapy (p=0.005; relative risk--relative risk [RR] 8.1, 95% confidence interval [CI] 1.9 to 34.8), homozygosity for C249T polymorphism in beta-fibrinogen gene (p=0.044; RR 8.4 95% CI 1.1 to 65.7), and percentage of all values of international normalized ratio within therapeutic interval 2.0-3.0 (p=0.009; RR 0.94, 95 CI 0.89 to 0.98).
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Acute Coronary Syndrome III: Diagnostic Studies